序号 |
标题 |
次数 |
作者 |
发布时间 |
86851 |
N-(2-丙炔基)-乙内酰脲 |
183 |
WYQ |
2024-11-22 |
86852 |
DOTA标记的c(RGDfK)环肽 |
133 |
kx |
2024-11-22 |
86853 |
DOTA-213biP 四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-213bip |
135 |
zcy |
2024-11-22 |
86854 |
DOTA-NHS ,四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
118 |
kx |
2024-11-22 |
86855 |
DOTA结合的生长抑素受体靶向肽 DOTA-SST |
123 |
zcy |
2024-11-22 |
86856 |
250612-06-7,DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2 |
101 |
kx |
2024-11-22 |
86857 |
HLys-DOTA d-异构体(RYWVAWRNRG)的聚阳离子肽偶联DOTA |
122 |
zcy |
2024-11-22 |
86858 |
DOTA-巯基;DOTA-Thiol;865470-67-3 |
89 |
wyh |
2024-11-22 |
86859 |
2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
110 |
wyh |
2024-11-22 |
86860 |
CQDs-DOTA-Gd 钆-DOTA螯合物功能化碳量子点 |
133 |
zcy |
2024-11-22 |
86861 |
DOTA-c(RGDfK) |
114 |
kx |
2024-11-22 |
86862 |
DOTA-PPB-01 DOTA-PPB-03 DOTA结合白蛋白 |
136 |
zcy |
2024-11-22 |
86863 |
(叠氮-四聚乙二醇)-(DOTA)-3K |
97 |
zyl |
2024-11-22 |
86864 |
DOTA Ala Ala COOH,DOTA-AA-OH的介绍 |
98 |
kx |
2024-11-22 |
86865 |
DOTAGA四叔丁酯;306776-79-4 |
133 |
wyh |
2024-11-22 |
86866 |
DOTA (1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸)-共轭偕二膦酸盐 |
131 |
zcy |
2024-11-22 |
86867 |
大环配体DOTA-TRIS(ACID)-AMIDO-DPEG 11-MALEIMIDE |
96 |
zyl |
2024-11-22 |
86868 |
IPB-DK(DOTA)-FAPI 大环化合物 |
125 |
zyl |
2024-11-22 |
86869 |
DOTA-Ala-Ala-Tyr-COOH的功能与应用 |
131 |
kx |
2024-11-22 |
86870 |
BCN-DOTA 环丙烷环辛炔-DOTA的结构式 |
139 |
zyl |
2024-11-22 |
86871 |
聚苯乙炔基苯基硅氧硼烷(PSOB) |
134 |
WYQ |
2024-11-22 |
86872 |
三苯乙炔基苯基硅烷(PTPES) |
118 |
WYQ |
2024-11-22 |
86873 |
(2,3-二油酰基-丙基)-三甲胺(MS盐)DOTAP |
136 |
kx |
2024-11-22 |
86874 |
含苯乙炔基聚硅氧烷(PE-PDMS) |
139 |
WYQ |
2024-11-22 |
86875 |
DOTA-C4-NH2;753421-63-5 |
102 |
wyh |
2024-11-22 |
86876 |
6-氨基-7-氟-4-丙炔基-1,4-苯并恶嗪-3(4H)-酮 |
118 |
WYQ |
2024-11-22 |
86877 |
N-丙炔基-4-氨基-4-氧代丁酸 |
115 |
WYQ |
2024-11-22 |
86878 |
4-Phenylacetyleneaniline,4-苯乙炔基苯胺(4-PEA) |
128 |
WYQ |
2024-11-22 |
86879 |
DOTA-4AMP;254444-71-8 |
126 |
wyh |
2024-11-22 |
86880 |
多肽化合物DOTA-(COOt-Bu)3-NHFmoc-Lys |
129 |
kx |
2024-11-22 |
86881 |
DOTA-(COOt-Bu)3-CH2-Alkynyl |
130 |
wyh |
2024-11-22 |
86882 |
聚乙二醇叠氮化物 ,DOTA-PEG5-azide |
95 |
kx |
2024-11-22 |
86883 |
DOTA-(CONH2)3 ;913528-04-8 |
93 |
wyh |
2024-11-22 |
86884 |
DOTA-EB-MCG DOTA螯合剂缀合伊文思蓝标记(R)-1-羧基-2-巯基乙基)氨基甲酰基)-l-谷氨酸 |
115 |
zcy |
2024-11-22 |
86885 |
cyclo(RGDFK(DOTA)) |
102 |
zyl |
2024-11-22 |
86886 |
4-苯乙炔基苯胺(p-PEA) |
132 |
WYQ |
2024-11-22 |
86887 |
cholecystokinin (26-33), indium-DOTA(0)-Asp(26)-Nle(28,31)- |
93 |
wyh |
2024-11-22 |
86888 |
Gd-DOTA-LAE Gd3+(钆离子)螯合1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-乳糖酸 |
719 |
zcy |
2024-11-22 |
86889 |
聚(2-乙炔基噻吩)(PET)(由2-乙炔基噻吩单体合成) |
121 |
WYQ |
2024-11-22 |
86890 |
DOTA-E[c(RGDyK)2],DOTA标记序列多肽 |
120 |
kx |
2024-11-22 |
86891 |
聚(二乙炔基苯-硅烷-硼烷)(PASB) |
153 |
WYQ |
2024-11-22 |
86892 |
CAS:446061-19-4 p-NH2-Bn-DOTA-tetra(t-Bu-ester) |
97 |
zyl |
2024-11-22 |
86893 |
2,4-二氨基[4'-(4-苯乙炔基酞酰亚胺基)]二苯醚(DPED) |
154 |
WYQ |
2024-11-22 |
86894 |
DOTA-cyclo(RGDfK) acetate;213187-44-1 |
108 |
wyh |
2024-11-22 |
86895 |
EuDOTAGly4( Eu4) 甘氨酸修饰DOTA |
103 |
zcy |
2024-11-22 |